Calcium Citrate and Vitamin D in the Treatment of Osteoporosis

被引:0
作者
José Manuel Quesada Gómez
Josep Blanch Rubió
Manuel Díaz Curiel
Adolfo Díez Pérez
机构
[1] Hospital Universitario Reina Sofía,Mineral Metabolism Unit
[2] Hospital Universitario Reina Sofía,IMAS Rheumatology Department
[3] Universidad Autónoma,Department of Internal Medicine/Bone Metabolism Disorders, Fundación Jiménez Díaz, Madrid, and Bone Metabolism Disorders
[4] Hospital del Mar-IMIM,Department of Internal Medicine and Infectious Diseases
[5] Universidad Autónoma de Barcelona,undefined
来源
Clinical Drug Investigation | 2011年 / 31卷
关键词
Osteoporosis; Calcium Carbonate; Teriparatide; Transient Receptor Potential Vanilloid; Calcium Oxalate;
D O I
暂无
中图分类号
学科分类号
摘要
The combination of calcium with vitamin D (vitamin D3 [colecalciferol]) forms the basis of preventive and therapeutic regimens for osteoporosis. A number of studies have suggested that the combination of calcium and vitamin D is effective when administered at respective dosages of at least 1200 mg and 800IU per day, although efficacy is, as expected, affected by patient compliance. Overall, treatment with this combination appears to be effective in reducing the incidence of non-vertebral and hip fractures. Also, in all drug studies (of antiresorptive and anabolic agents and strontium ranelate) that demonstrated a reduction in risk of osteoporotic fractures, patients also took calcium and vitamin D supplements. An important finding in this regard is that vitamin D levels have been demonstrated to be inadequate in more than half of women treated for osteoporosis in the US and Europe.
引用
收藏
页码:285 / 298
页数:13
相关论文
共 50 条
  • [41] Should we prescribe calcium or vitamin D supplements to treat or prevent osteoporosis?
    Bolland, M. J.
    Grey, A.
    Reid, I. R.
    [J]. CLIMACTERIC, 2015, 18 : 22 - 31
  • [42] Cyclical etidronate and calcium carbonate (with citrate) supplementation for osteoporosis unmasking primary hyperparathyroidism
    Forbes, RB
    Grant, DJ
    MacWalter, RS
    [J]. SCOTTISH MEDICAL JOURNAL, 1995, 40 (06) : 177 - 178
  • [43] Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
    Body, J. -J.
    Bergmann, P.
    Boonen, S.
    Devogelaer, J. -P.
    Gielen, E.
    Goemaere, S.
    Kaufman, J. -M.
    Rozenberg, S.
    Reginster, J. -Y.
    [J]. OSTEOPOROSIS INTERNATIONAL, 2012, 23 : S1 - S23
  • [44] Salivary biomarkers (Vitamin D, Calcium, and Estrogen Hormone) in postmenopausal women with osteoporosis
    AL-Amiry, Ameera Y.
    Najem, Areej A.
    [J]. JOURNAL OF INDIAN ACADEMY OF ORAL MEDICINE AND RADIOLOGY, 2023, 35 (01) : 41 - 44
  • [45] Extraskeletal benefits and risks of calcium, vitamin D and anti-osteoporosis medications
    J.-J. Body
    P. Bergmann
    S. Boonen
    J.-P. Devogelaer
    E. Gielen
    S. Goemaere
    J.-M. Kaufman
    S. Rozenberg
    J.-Y. Reginster
    [J]. Osteoporosis International, 2012, 23 : 1 - 23
  • [46] Beyond calcium and Vitamin D: Is there a role for other vitamins, minerals, and nutrients in osteoporosis?
    O'Neil C.K.
    Evans E.
    [J]. Clinical Reviews in Bone and Mineral Metabolism, 2004, 2 (4): : 325 - 339
  • [47] Vitamin D and calcium in patients with osteoporosis following the Women's Health Initiative
    Lips, Paul
    [J]. CLINICAL CASES IN MINERAL AND BONE METABOLISM, 2006, 3 (02) : 184 - 187
  • [48] Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: A 3 year followup
    Adachi, JD
    Bensen, WG
    Bianchi, F
    Cividino, A
    Pillersdorf, S
    Sebaldt, RJ
    Tugwell, P
    Gordon, M
    Steele, M
    Webber, C
    Goldsmith, CH
    [J]. JOURNAL OF RHEUMATOLOGY, 1996, 23 (06) : 995 - 1000
  • [49] Plain vitamin D or active vitamin D in the treatment of osteoporosis: where do we stand today?
    Ringe, Johann Diederich
    [J]. ARCHIVES OF OSTEOPOROSIS, 2020, 15 (01)
  • [50] Plain vitamin D or active vitamin D in the treatment of osteoporosis: where do we stand today?
    Johann Diederich Ringe
    [J]. Archives of Osteoporosis, 2020, 15